Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
247.0500 0.05 (0.02%)
NSE Jun 26, 2025 15:31 PM
Volume: 772.0K
 

247.05
0.02%

Marksans Pharma

Centrum Broking
Recommendation and key risks: We have revised our FY18E and FY19E EPS downwards by 3% and 19% respectively. We upgrade MPL to Buy from Hold rating, with a TP of Rs55 based on 18x March'20E EPS of Rs3.0, and a 45.3% upside from CMP. Key positive upsides would be additional ANDA approvals from US FDA and...
Marksans Pharma Ltd. has gained 52.46% in the last 1 Year
More from Marksans Pharma Ltd.
Recommended